INCYTE CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
INCYTE CORPORATION (INCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 1.42 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-02-10
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2011-09-30 was 490.00K shares.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 1.42M shares, a 6.11% increase from fiscal 2024.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 1.34M shares, a 7.39% decline from fiscal 2023.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 1.44M shares, a 22.29% decline from fiscal 2022.
- INCYTE CORPORATION share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 1.86M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2025-12-31 | 1.42M shares 10-K · filed 2026-02-10 | |||
| 2024-12-31 | 1.34M shares 10-K · filed 2025-02-10 | |||
| 2023-12-31 | 1.44M shares 10-K · filed 2024-02-13 | |||
| 2022-12-31 | 1.86M shares 10-K · filed 2023-02-07 | |||
| 2011-09-30 | 490.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | 4.87M shares 10-Q · filed 2011-10-27 | ||
| 2011-06-30 | 4.38M shares 10-Q · filed 2011-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |